The role of health risk factors and disease on worker productivity

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 10, 1999, Pages 863-877

  Burton, Wayne N ^a,b   Conti, Daniel J ^a,c   Chen, Chin Yu ^d   Schultz, Alyssa B ^d   Edington, Dee W ^d  

^a Bank One   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DEPAUL UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ARTICLE; COST BENEFIT ANALYSIS; DISABILITY; HEALTH CARE COST; HUMAN; JOB PERFORMANCE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PERSONNEL MANAGEMENT; PRODUCTIVITY; RISK ASSESSMENT; RISK FACTOR;

ABSENTEEISM; ADULT; EFFICIENCY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIFE STYLE; OCCUPATIONAL DISEASES; RISK ASSESSMENT; RISK FACTORS; SICK LEAVE;

EID: 0032737086     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199910000-00007     Document Type: Article

References (46)

1. Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med. 1997; 39:320-327.
2. Warshaw LJ, Burton WN. Cutting the costs of migraine: role of the employee health unit. J Occup Environ Med. 1998; 40:943-953.
3. Greenberg PE, Finkelstein SN, Berndt ER. Economic consequences of illness in the workplace. Sloan Manage Rev. 1995; 36:26-38.
4. Conti DJ, Burton WN. The economic impact of depression in a workplace. J Occup Environ Med 1994;36:983-988.
5. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264: 2524-2528.
6. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol. 1995;95:1097-1110.
7. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA. 1998;280:1490-1496.
8. Rizzo JA, Abott TA, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ. 1996;5:249-265.
9. Yen L, Edington DW, Witting P. Prediction of prospective medical claims and absenteeism costs for 1284 hourly workers from a manufacturing company. J Occup Environ Med. 1992;34:428-435.
10. Bertera RL. The effects of behavioral risks on absenteeism and health-care costs in the workplace. J Occup Environ Med. 1991;33:1119-1124.
11. Smith KJ, Everly Jr. GS, Haight GT. An empirical analysis of the impact of a corporate health promotion intervention on reported sick leave absenteeism. Benefits Q. 1990;6:37-45.
12. Wood EA, Olmstead GW, Craig JL. An evaluation of lifestyle risk factors and absenteeism after two years in a worksite health promotion program. Am J Health Promot. 1989;4:128-133.
13. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333:889-893.
14. Stempel DA, Thomas M. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus non-sedating antihistamines. Am J Manag Care. 1998;4:89-96.
15. Adelsberg BR. Sedation and performance issues in the treatment of allergic conditions. Arch Intern Med. 1997;157:494-500.
16. Kay GG, Berman B, Mackoviak SH, et al. Initial and steady-state effects of diphenhydramine and loratadine (Claritin) on sedation, cognition mood, and psychomotor performance. Arch Intern Med. 1997;157:2350-2356.
17. Chirban JT, Jacobs RJ, Warren J, et al. The 36-item short form health survey (SF-36) and work productivity and impairment (WPAI) questionnaire in panic disorder. Disease Manage Health Outcomes. 1997;1:154-164.
18. Jacobs RJ, Davidson JRT, Gupta S, Meyerhof'f AS. The effects of clorazepam on quality of life and work productivity in panic disorder. Am J Manag Care. 1997; 3:1187-1196.
19. Reilly MC, Zbrozek AS, Duke EM. The validity and reproducibility of a work productivity and impairment instrument. Pharmacoeconomics. 1993;4:353-365.
20. Edlund MJ, Swann AV. The economic and social costs of panic disorder. Hosp Community Psychiatry. 1987;38:1277-1279.
21. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ. 1998;17:511-535.
22. Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait G. Sumatriptan injection reduces productivity loss during a migraine attack. Arch Intern Med. 1998;158:1013-1018.
23. Jhingran P, Cady RK, Runino J, Miller D, Grice RB, Gutterman DL. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Pract. 1996;42:36-42.
24. SAS Institute Inc. SAS© Language: Reference, Version 6, 1st ed. Cary, NC: SAS Institute Inc.; 1990.
25. The Diabetes Control and Complications Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
26. United Kingdom Prospective Diabetes Study (UKPDS) Group. UKPDS 13: relative efficacy of randomly allocated diet, sulfonylurea, insulin or metformin in patients with newly diagnosed noninsulin dependent diabetes followed for three years. BMJ. 1995;310:83-88.
27. Cryer PE, Binder C, Bolli GB, et al. Hypoglycemia in IDDM. Diabetes. 1989; 38:1193-1199.
28. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes. 1992;41:255-260.
29. Draelos MT, Jacobson AM, Weinger MA, et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med. 1995;98:135-144.
30. Gonder-Frederick LA, Cox DJ. Symptom and blood glucose feedback in the self-treatment of IDDM. In: Holmes CS, ed. Neuropsychological and Behavioral Aspects of Diabetes. New York, NY: Springer-Verlag; 1990:155-174.
31. Weinger K, Jacobson AM, Draelos MT, et al. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. Am J Med. 1995;98:22-31.
32. Burton WN, Connerty CM. Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med. 1998;40:702-706.
33. Burton WN, Chen CY, Schulz AB, Edington DW. The economic costs associated with body mass index in a workplace. J Occup Environ Med. 1998;40: 786-792.
34. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-660.
35. Colditz GA. Economic costs of obesity. Am J Clin Nutr. 1992;55:503S-507S.
36. Narbo K, Jonsson E, Larsson B, Waaler J, Wedel H, Sjostrom L. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes Relat Metab Disord. 1996;20:895-903.
37. Levy E, Levy P. Le Pen C, Basdevant A. The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord. 1995;19:788-792.
38. Gorsky RD, Pamuk E, Williamson DF, Shaffer PA, Koplan JP. The 25-year health care costs of women who remain overweight after 40 years of age. Am J Prev Med. 1996;12:388-394.
39. Quick JC. Introduction to the measurement of stress at work. J Occup Health Psychology. 1998;3:291-293.
40. Cooper, CL, Cartwright, S. Healthy mind, healthy organization: a proactive approach to occupational stress. Hum Relat. 1994;47:455-470.
41. Karasek RA, Theorell T Healthy Work: Stress, Productivity, and the Reconstruction of Working Life. New York: Basic Books, 1990.
42. Quick JC, Quick JD, Nelson DL, Hurrell JJ Preventive Stress Management in Organizations. Washington, DC: American Psychological Association; 1997.
43. Burton WN, Conti DJ. Use of an integrated health data warehouse to measure the employer costs of five chronic disease states. Disease Manage. 1998;1:17-26.
44. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
45. Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected. Cambridge, MA: Harvard School of Public Health; 1996.
46. Conti DJ, Burton WN. Behavioral health disability management. In: Oher JM, ed. The Employee Assistance Handbook. New York, NY: J. Wiley & Sons; 1999.